Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:15 pm Purchase |
2025-04-15 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 205,465 2.200% |
205,465 (New Position) |
Filing History |
| 2024-12-18 5:10 pm Unchanged |
2024-12-17 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.500% |
0 (Unchanged) |
Filing History |
| 2024-10-30 4:21 pm Unchanged |
2024-10-23 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.500% |
0 (Unchanged) |
Filing History |
| 2023-07-25 4:40 pm Unchanged |
2023-07-25 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.700% |
0 (Unchanged) |
Filing History |
| 2023-07-07 09:17 am Purchase |
2023-07-06 | 13G | Elicio Therapeutics, Inc. ELTX |
Vifor (International) Ltd. | 199,564 0.020% |
199,564 (New Position) |
Filing History |
| 2022-03-30 3:51 pm Purchase |
2021-02-09 | 13G | Angion Biomedica Corp. ANGN |
Vifor (International) Ltd. | 199,564 6.700% |
199,564 (New Position) |
Filing History |
| 2021-10-21 4:15 pm Purchase |
2021-10-20 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 616,398 13.900% |
273,533 (+79.78%) |
Filing History |
| 2021-10-13 6:54 pm Sale |
2021-10-12 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 5,194,085 7.400% |
-4,089,660 (-44.05%) |
Filing History |
| 2020-10-23 4:05 pm Purchase |
2020-10-15 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 342,865 8.300% |
342,865 (New Position) |
Filing History |
| 2020-07-31 4:54 pm Sale |
2020-07-30 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 9,283,745 13.700% |
-693,378 (-6.95%) |
Filing History |
| 2020-07-16 07:56 am Sale |
2020-07-14 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 9,977,123 14.700% |
-699,702 (-6.55%) |
Filing History |